17 Potential Alzheimer’s Drugs to Be Focus of Alzheimer’s Talks Teleconference on April 11

17 Potential Alzheimer’s Drugs to Be Focus of Alzheimer’s Talks Teleconference on April 11
Two important Alzheimer’s research organizations, Researchers Against Alzheimer’s (RA2) and Us Against Alzheimer’s (UsA2), will host an Alzheimer’s Talks Teleconference on April 11 to discuss recently released findings of an analysis of late-stage drug candidates to treat the disease. Significant findings in the analysis, released in March, include: There are 17 drugs in late-stage development (Phase 3 clinical trials), with the

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *